Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Retained Earnings (2016 - 2025)

Macrogenics (MGNX) has disclosed Retained Earnings for 14 consecutive years, with -$1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 6.38% to -$1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 billion, a 6.38% decrease, with the full-year FY2025 number at -$1.2 billion, down 6.38% from a year prior.
  • Retained Earnings was -$1.2 billion for Q4 2025 at Macrogenics, down from -$1.2 billion in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$823.1 million in Q1 2021 to a low of -$1.2 billion in Q2 2025.
  • A 5-year average of -$1.1 billion and a median of -$1.1 billion in 2022 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: dropped 26.4% in 2022, then grew 4.5% in 2023.
  • Macrogenics' Retained Earnings stood at -$973.9 million in 2021, then dropped by 12.3% to -$1.1 billion in 2022, then fell by 0.83% to -$1.1 billion in 2023, then dropped by 6.07% to -$1.2 billion in 2024, then decreased by 6.38% to -$1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Retained Earnings are -$1.2 billion (Q4 2025), -$1.2 billion (Q3 2025), and -$1.2 billion (Q2 2025).